AJCP / Meeting AbstrActs stemming from a poor molecular and genetic characterization. The malignant character of a heart mass cannot be truly determined until pathology evaluation. We present the case of a 72-year-old man who presented with cardiomegaly and several bilateral lung nodules after being examined for shortness of breath and hemoptysis. A percutaneous CT guided biopsy of the right atrial wall was diagnostic of angiosarcoma based on histology and positivity for anti-CD31.
Angioleiomyomas or vascular leiomyomas are a benign group of slow-growing tumors arising from the smooth muscle of blood vessel walls. Although rare, they are usually found within the uterus, extremities, and gastrointestinal tract. Angioleiomyoma occurs rarely in head and neck region, with lips, ears, and nose being the most involved sites, and it can present with various symptoms depending on the exact location. We report the case of a 73-year-old man who presented with severe dysphonia. Direct laryngoscopy revealed large mass involving the anterior third of left true vocal cord in the larynx. Biopsy of the lesion demonstrates benign squamous mucosa with an underlying submucosal proliferation of smooth muscle cells admixed with thickened blood vessels. Immunohistochemical stains reveal that tumor cells are positive for muscle specific actin while negative for HMB45, CK AE1/AE3, and S100. This profile is compatible with diagnosis of angioleiomyoma. In recent follow-up visit five months after laryngoscopic excision, the patient had no symptoms or signs of tumor recurrence. Fewer than 30 cases of laryngeal angioleiomyoma were reported in the literature. The tumor has male predominance and variable occurrence sites in larynx, with the supraglottic region being the most common. The main documented symptoms of reported cases are hoarseness, dyspnea, dysphagia, and foreign body sensation. There is no standardized treatment for laryngeal leiomyoma due to its rarity, but complete lesion resection is the most commonly chosen one. The choice of excision procedure between direct laryngoscopy and open neck approach is decided by tumor size, expected amount of blood loss, and any comorbidity the patient might have. Preoperative embolization of tumor before transoral resection has sometimes been recommended. Also, small lesions can be amenable to laser resection. Introduction: Hypocalcemia is a known risk in patients undergoing total thyroidectomy due to injury or removal of parathyroids. There is considerable variation in calcium monitoring practice patterns among surgeons performing thyroidectomies, and varying recommendations in the otolaryngology literature. Often, surgeons order multiple calcium and parathyroid hormone (PTH) assays to aid in postoperative decision making. The purpose of our study was to combine the expertise of pathology and otolaryngology to establish a standardized practice for postoperative calcium monitoring that provided adequate information for patient management, while not initiating excessive testing. Methods: Laboratory test ordering practices were abstracted from our clinical improvement database. Cases were identified from billing data for cases coded total thyroidectomy from June 2012 to June 2016. For each operative encounter, the number of calcium and PTH tests were recorded, along with the lab values. Discharge summaries and follow-up notes were searched for signs and/or symptoms of hypocalcemia, and whether patients presented to the emergency department or were readmitted within 30 days of discharge secondary to hypocalcemia. These data were used to plan the testing protocol, which was established as obtaining one PTH assay within one hour of gland removal, and discharging all patients on a tapering dose of calcium, with the addition of vitamin D for patients with a PTH level less than 10 pg/mL. Patients were followed for signs and/or symptoms of hypocalcemia, emergency department visits. or readmissions within 30 days of discharge secondary to hypocalcemia. Compliance with the protocol was monitored. Conclusion: There was considerable variation in test ordering among our surgeons, without a significant difference in patient outcome. After initiating our standardized protocol, utilization dropped significantly, without an increase in symptomatic hypocalcemia. The surgeons found this protocol easy to follow, and no longer felt they had to wait for test results for discharge. 
